These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking. Liu J; Hutzler M; Li C; Pechet L J Thromb Thrombolysis; 2001 May; 11(3):261-72. PubMed ID: 11577265 [TBL] [Abstract][Full Text] [Related]
43. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. George JN Curr Opin Hematol; 2003 Sep; 10(5):339-44. PubMed ID: 12913787 [TBL] [Abstract][Full Text] [Related]
44. Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia. Fabian E; Eisner F; Pabinger I; Viertler C; Regauer S; Lueger A; Neumeister P; Weiss EC; Schöll W; Lang U; Prüller F; Krejs GJ Wien Klin Wochenschr; 2015 Sep; 127(17-18):707-14. PubMed ID: 26248584 [No Abstract] [Full Text] [Related]
45. [Thrombotic thrombopenic purpura (TTP) and hemolytic uremic syndrome (HUS) - differentiation of the clinical characteristics]. Yamada K Nihon Rinsho; 1975 Dec; 33(12):3402-10. PubMed ID: 1240467 [No Abstract] [Full Text] [Related]
46. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13. Chapman K; Seldon M; Richards R Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603 [TBL] [Abstract][Full Text] [Related]
47. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. Terrell DR; Williams LA; Vesely SK; Lämmle B; Hovinga JA; George JN J Thromb Haemost; 2005 Jul; 3(7):1432-6. PubMed ID: 15978100 [TBL] [Abstract][Full Text] [Related]
48. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550 [TBL] [Abstract][Full Text] [Related]
49. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Furlan M Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284 [TBL] [Abstract][Full Text] [Related]
50. Not known from ADAM(TS-13)--novel insights into the pathophysiology of thrombotic microangiopathies. Wolf G Nephrol Dial Transplant; 2004 Jul; 19(7):1687-93. PubMed ID: 15128885 [No Abstract] [Full Text] [Related]
52. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. George JN; Chen Q; Deford CC; Al-Nouri Z J Clin Apher; 2012; 27(6):302-11. PubMed ID: 22927184 [TBL] [Abstract][Full Text] [Related]
58. Clinical utility of ADAMTS-13 testing in suspected thrombotic microangiopathy: an audit of ADAMTS-13 activity assay requests in routine practice from a tertiary hospital. Garizio DG; Wilgen U; Williams BA; Kennedy GA Pathology; 2012 Dec; 44(7):638-41. PubMed ID: 23089737 [TBL] [Abstract][Full Text] [Related]
60. Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): important discrimination from Upshaw-Schulman syndrome. Ashida A; Nakamura H; Yoden A; Tamai H; Ishizashi H; Yagi H; Matsumoto M; Fujimura Y Am J Hematol; 2002 Dec; 71(4):318-22. PubMed ID: 12447964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]